The primer mix has been verified to generate satisfactory qPCR data on Roche Applied-science LightCycler® 480 Ⅱ.
储存 & 运输
Lyophilized qPCR primer mix is shipped at ambiente temperatura
The lyophilized product is stable for one year from date of receipt when stored at -20℃.
The suspended product is stable for six months from date of receipt when stored at -20℃.
***Sino biological qEASY qPCR primer pairs are used for SYBR Green-based real-time RT-PCR, The primers are designed by using SBI's proprietary primer design algorithm. Our primer collection covers the entire human genomes. It can be widely applied in the quantitative analysis of gene expression.***
在特定基因的不同变体保守区内设计引物，该对引物至少有一条引物跨越内含子或产物跨越内含子，有效避免基因组 DNA 的扩增。
用质粒标准品对 qPCR 引物的灵敏度、扩增效率和特异性进行筛选，用阳性组织或细胞验证确认。
统一的 PCR 条件，操作方便，节约时间与成本
~100% 的扩增效率，保证 RNA 定量的准确性
Human ADH5 qPCR Primer Pair: 别称
ADH-3 qPCR Primer Pairs, Human; ADHX qPCR Primer Pairs, Human; FALDH qPCR Primer Pairs, Human; FDH qPCR Primer Pairs, Human; GSH-FDH qPCR Primer Pairs, Human; GSNOR qPCR Primer Pairs, Human
Carbonic anhydrases IX (CAIX), also known as membrane antigen MN or CA9, is a member of the carbonic anhydrase (CA) family and may be involved in cell proliferation and cellular transformation. CAs are zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide ( H2O + CO2 = H+ + HCO3- ) and thus participate in a variety of biological and physical processes. CAIX is a transmembrane protein structurally consisting of a signal peptide, a proteoglycan-related region, a CA domain with a highly conserved active site, a transmembrane anchor and an intracytoplasmic tail, and is the only tumor-associated CA isoenzyme known so far. Compared with normal tissues, CAIX is overexpressed in a wide spectrum of tumor types and associated with increased metastasis and poor prognosis in aggressive carcinomas. CAIX expression is cell density dependent and has been shown to be strongly induced by hypoxia, accordingly facilitates adaptation of tumor cells to hypoxic conditions. CA9 is regarded as a new therapeutic target for CA9-derived carcinomas.
alcohol dehydrogenase 5 (class III), chi polypeptide
Pastorek, J. et al., 1994, Oncogene. 9: 2877-88.
Opavsky, R. et al., 1996, Genomics. 33: 480-7.
Swietach, P. et al., 2008, J. Biol. Chem. 283: 20473-83.
Robertson, N. et al., 2004, Cancer. Res. 64: 6160-5.
Bui, M.H. et al., 2003, Clin. Cancer. Res. 9: 802-11.
Choi, S.W. et al., 2008, Hum. Pathol. 39: 1317-22.